Results 231 to 240 of about 59,185 (303)

The inactivated herpes zoster vaccine HZ/su induces a varicella zoster virus specific cellular and humoral immune response in patients on dialysis. [PDF]

EBioMedicine
Hielscher F, Schmidt T, Enders M, Leyking S, Gerhart M, van Bentum K, Mihm J, Schub D, Sester U, Sester M.   +9 more
europepmc   +1 more source

Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy. [PDF]

Vaccines (Basel)
Ceccarelli A, Tamarri F, Angelini R, Bakken E, Concari I, Giannoccaro E, Domeniconi G, Morri M, Reali C, Righi F, Serra S, Semprini G, Silvestrini G, Turri V, Gori D, Montalti M.   +15 more
europepmc   +1 more source

Factors Influencing Herpes Zoster Vaccine Utilization Among Adults Aged 50 and Above Attending Primary Healthcare Center in Saudi Arabia: A Cross-Sectional Study. [PDF]

Cureus
Almakhdob M, Selim M, Abdalrouf A.
europepmc   +1 more source

Herpes Zoster and Varicella Encephalitis Following the Recombinant Zoster Vaccine [PDF]

Mallory Pane
openalex   +1 more source

Herpes zoster triggered by ChAdOx1 nCoV-19 coronavirus vaccine (recombinant) [PDF]

Neethu George
openalex   +1 more source

Detection of viruses in clinical samples by use of metagenomic sequencing and targeted sequence capture [PDF]

, 2018
Buller, Richard, Cannella, Maria T, Herter, Brandi, Storch, Gregory A, Wylie, Kristine M, Wylie, Todd N   +5 more
core   +1 more source

Vaccinations: "not just for kids” [PDF]

, 2018
Michel, Jean-Pierre
core  

The Efficacy, Immunogenicity and Safety of a Recombinant Tetrameric GE-FC Fusion Protein Vaccine for Herpes Zoster in Adults 40 Years of Age or Older: A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial

Pengfei Jin, Yaru Quan, Xuefen Gao, Mingwei Wei, Xiang Cao, Hongxing Pan, Heng Tao Shen, Qili Zhang, Qing Xu, Zhao Wang, Xiaodong Liu, Jinmei Xu, Kang-Wei Xu, William Wan, Yeqing Tong, Li Zhang, Lin Xu, Jingxin Li, anon Group   +18 more
openalex   +1 more source

P-17. Worldwide Impact of Increased Recombinant Zoster Vaccine Coverage on the Burden of Herpes Zoster, based on 11-year Clinical Trial Follow-up Data, in Adults Aged ≥50 Years

Desmond Curran, Sean Matthews, Nikolaos Giannelos   +2 more
openalex   +1 more source